Cancer Treatment Denied in New York? How to Challenge the Decision
New York has robust external review rights for cancer denials. If Emblem, BCBS, or another insurer denied your oncology treatment, here's your step-by-step guide.
Cancer Treatment Denied in New York? How to Challenge the Decision
New York State has some of the strongest patient protection laws in the country, and that extends to cancer treatment denials. If your insurer has denied chemotherapy, immunotherapy, radiation, surgery, a targeted therapy, or enrollment in a clinical trial, New York law gives you a clear pathway to fight back — including access to an independent External Independent Review: Complete Guide" class="auto-link">external review that carries legal force.
Why New York Insurers Deny Cancer Treatment
The most common denial reasons for cancer treatment in New York follow familiar patterns:
"Not medically necessary" — Insurers apply internal clinical policy guidelines that may not align with current NCCN (National Comprehensive Cancer Network) standards or the recommendations of your New York oncologist. This is the denial reason most frequently overturned on external review.
"Experimental or investigational" — New York law explicitly requires certain plans to cover the routine costs of approved clinical trials. If your insurer is citing "investigational" status to deny a treatment that NCCN guidelines list as a Category 1 recommendation, that denial is legally vulnerable.
"Off-label drug use" — New York Insurance Law § 3238 requires fully insured health plans to cover FDA-approved drugs used for off-label cancer treatment when supported by peer-reviewed literature or standard oncology compendia. This is one of the most powerful protections available to New York cancer patients.
Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization delays — New York's prior authorization reform laws (including Chapter 533 of the Laws of 2018) impose timelines on insurers and require expedited review for urgent cancer cases.
Out-of-network cancer center — Memorial Sloan Kettering, Weill Cornell Medicine, and other premier New York cancer centers may be out of network for some plans. New York's network adequacy rules may give you grounds to challenge a network-based denial.
Key New York Laws for Cancer Patients
New York Insurance Law § 3238 — Mandates coverage for off-label use of FDA-approved drugs in cancer treatment when supported by evidence-based oncology references. Violations are enforceable by the NY Department of Financial Services.
New York Insurance Law § 3217-e (clinical trials) — Requires certain plans to cover routine costs of patient participation in approved cancer clinical trials.
New York's External Appeal Law (Insurance Law § 4910) — Provides robust access to external review by independent organizations certified by the state. External reviewers are not beholden to the insurer and apply current clinical evidence. New York's external appeal overturn rate for cancer denials is significant.
New York's prior authorization transparency law — Requires insurers to disclose the clinical criteria used to make prior authorization decisions, making it easier to challenge denials that are inconsistent with published guidelines.
Major Insurers in New York
EmblemHealth / GHI is one of the largest not-for-profit insurers in New York, serving hundreds of thousands of members in the NYC metro area. EmblemHealth's medical policies for oncology treatments have been challenged in numerous external reviews, particularly for newer targeted therapies.
ClaimBack generates a professional appeal letter in 3 minutes — citing real insurance regulations for your country. Get your free analysis →
Oscar Health is a New York-based technology-driven insurer that serves individual and small group markets. Oscar's prior authorization process for complex oncology treatments can be difficult to navigate, and delays are a common complaint.
Anthem Empire Blue Cross Blue Shield (now Anthem HealthKeepers Plus and Empire BlueCross) is a major presence in the New York market. Anthem's national clinical guidelines sometimes differ from current NCCN standards, leading to denials that are frequently overturned on appeal.
United Healthcare operates throughout New York, particularly in employer-sponsored plans and Medicare Advantage. UHC's oncology prior authorization requirements are among the most burdensome in the industry.
Healthfirst is a large Medicaid and Medicare Advantage plan in New York City. Healthfirst oncology denials have a different appeals pathway that intersects with federal Medicaid and Medicare rules.
Memorial Sloan Kettering and New York Cancer Centers
Memorial Sloan Kettering Cancer Center in Manhattan is one of the world's foremost cancer treatment and research institutions. MSK is in-network for many New York plans, but not all. If your insurer is denying care because MSK is out of network — despite MSK being the clinically appropriate facility for your cancer type — New York's continuity of care laws and network adequacy rules may provide grounds for appeal.
Other major New York cancer centers include Roswell Park Comprehensive Cancer Center in Buffalo (an NCI-designated center), Weill Cornell Medicine Comprehensive Cancer Center, Mount Sinai Tisch Cancer Center, and NYU Langone Perlmutter Cancer Center.
How to File a Cancer Appeal in New York
Step 1 — Get the denial in writing. Request the full denial letter, the EOB)" class="auto-link">Explanation of Benefits, and the specific clinical criteria your insurer applied. You are legally entitled to this documentation.
Step 2 — File an internal appeal. Submit a written appeal within 180 days of the denial. Include:
- A detailed letter of medical necessity from your oncologist, referencing NCCN guidelines
- Supporting clinical literature (published studies, clinical trial data)
- Your diagnosis documentation, pathology reports, staging information
- Specific citation of New York Insurance Law § 3238 (if off-label drug) or § 3217-e (if clinical trial)
Step 3 — Request external appeal. After an adverse internal decision, file for external appeal with the NY Department of Financial Services. The DFS administers New York's external appeal program. File at dfs.ny.gov or call 800-342-3736. External decisions are legally binding on the insurer.
Step 4 — File a DFS complaint. If you believe the insurer violated state law, file a separate complaint with NY DFS. The DFS has broad enforcement authority and takes oncology mandate violations seriously.
Expedited Review for Urgent Cases
New York law requires expedited external review decisions within 72 hours when a delay would seriously jeopardize your health. If you are in an active treatment cycle or your oncologist certifies urgency, invoke the expedited review pathway immediately.
Fight Back With ClaimBack
A cancer treatment denial in New York is not final. You have the right to an independent review, and that review frequently results in coverage being ordered. ClaimBack helps you build a complete appeal — oncologist letter, statutory citations, clinical evidence — organized for maximum impact.
Start your New York cancer appeal with ClaimBack.
Related Reading
How much did your insurer deny?
Enter your denied claim amount to see what you could recover.
Your insurer is counting on you giving up.
Most people do. Less than 1% of denied claimants ever appeal — even though the majority who do win. ClaimBack was built by people who were denied, who fought back, and who refused to accept "no" from an insurer.
We give you the same appeal arguments that attorneys use — in 3 minutes, for free. Your denial deadline is ticking. Don't let it expire.
Free analysis · No credit card · Takes 3 minutes
Related ClaimBack Guides